Puma Biotechnology, Inc. (PBYI) Stock Plunged 17.84% After-Hours, Here’s Why
Puma Biotechnology, Inc. (PBYI) stock plummeted 17.84% in the after-hours trading session at the price of $5.25 after announcing its earnings report for the third quarter ended on 30th September 2021. PBYI is a biopharmaceutical firm that develops and commercializes innovative products to improve cancer care. PBYI Third Quarter 2021 Financial Results On 4th November […]
Insider Selling: Puma Biotechnology Inc. [PBYI] Pres, CEO, 10% Sells 18,235 Shares Worth $186,380
On Jan. 04, Auerbach Alan H divested U.S. $186,380 in shares of Puma Biotechnology Inc.. The Pres, CEO, 10% sold 18,235 shares at a price per share of $10.22. The transaction decreased this specific insider’s holdings to 4,284,258 shares worth around $45.67 million at present. Meanwhile, Goldman had lowered its rating on PBYI to “Sell” […]
